Yearly Licence Tolerability and Immunogenicity Study of Fluval AB Seasonal Influenza Vaccine to be Used in the 2012/2013 Vaccination Season
NCT01649713
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
120
Enrollment
INDUSTRY
Sponsor class
Conditions
Influenza
Interventions
DRUG:
Fluval AB vaccination
Sponsor
Fluart Innovative Vaccine Ltd, Hungary